Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial

Respiratory Distress ◽

Clinical Outcomes ◽

Distress Syndrome ◽

Controlled Trial ◽

Faculty Opinions recommendation of Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13410980.14847075 ◽

2012 ◽

Author(s):

Greg Martin

Keyword(s):

Respiratory Distress ◽

Clinical Outcomes ◽

Distress Syndrome ◽

Controlled Trial ◽

Faculty Opinions recommendation of Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13410980.14782090 ◽

2011 ◽

Author(s):

Michael O'Connor

Keyword(s):

Respiratory Distress ◽

Clinical Outcomes ◽

Distress Syndrome ◽

Controlled Trial ◽

Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial

Trials ◽

10.1186/s13063-020-04488-8 ◽

2020 ◽

Vol 21 (1) ◽

Cited By ~ 4

Author(s):

J. P. Desilles ◽

C. Gregoire ◽

C. Le Cossec ◽

J. Lambert ◽

O. Mophawe ◽

...

Keyword(s):

Respiratory Distress ◽

Study Protocol ◽

Distress Syndrome ◽

Controlled Trial ◽

Efficacy And Safety ◽

Dornase Alfa ◽

Hydrocortisone in treatment of severe sepsis and septic shock with acute respiratory distress syndrome: a randomised controlled trial

Intensive Care Medicine Experimental ◽

10.1186/2197-425x-3-s1-a808 ◽

2015 ◽

Vol 3 (S1) ◽

Cited By ~ 2

Author(s):

S Tongyoo ◽

C Permpikul ◽

V Vattanavanit ◽

W Mongkolpun

Keyword(s):

Septic Shock ◽

Severe Sepsis ◽

Respiratory Distress ◽

Distress Syndrome ◽

Controlled Trial ◽

Randomised Controlled ◽

Sepsis And Septic Shock

High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial

Trials ◽

10.1186/s13063-020-04646-y ◽

2020 ◽

Vol 21 (1) ◽

Cited By ~ 3

Author(s):

Luis Patricio Maskin ◽

Gabriel Leonardo Olarte ◽

Fernando Palizas ◽

Agostina E. Velo ◽

María Fernanda Lurbet ◽

...

Keyword(s):

Respiratory Distress ◽

Distress Syndrome ◽

Controlled Trial ◽

High Dose ◽

Dexamethasone Treatment ◽

High Dose Dexamethasone ◽

Rosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: an ancillary study to a randomised controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(16)00005-9 ◽

2016 ◽

Vol 4 (3) ◽

pp. 203-212 ◽

Cited By ~ 59

Author(s):

Dale M Needham ◽

Elizabeth Colantuoni ◽

Victor D Dinglas ◽

Catherine L Hough ◽

Amy W Wozniak ◽

...

Keyword(s):

Intensive Care ◽

Cognitive Impairment ◽

Respiratory Distress ◽

Distress Syndrome ◽

Controlled Trial ◽

Ancillary Study ◽

A randomised controlled trial of an open lung strategy with staircase recruitment, titrated PEEP and targeted low airway pressures in patients with acute respiratory distress syndrome

Critical Care ◽

10.1186/cc10249 ◽

2011 ◽

Vol 15 (3) ◽

pp. R133 ◽

Cited By ~ 79

Author(s):

Carol L Hodgson ◽

David V Tuxen ◽

Andrew R Davies ◽

Michael J Bailey ◽

Alisa M Higgins ◽

...

Keyword(s):

Respiratory Distress ◽

Distress Syndrome ◽

Controlled Trial ◽

Open Lung ◽

Airway Pressures ◽

Faculty Opinions recommendation of Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.733764749.793567294 ◽

2019 ◽

Author(s):

Kathryn Anne Hibbert

Keyword(s):

Respiratory Distress ◽

Distress Syndrome ◽

Controlled Trial ◽

Secondary Analysis ◽

Differential Response ◽

Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(18)30177-2 ◽

2018 ◽

Vol 6 (9) ◽

pp. 691-698 ◽

Cited By ~ 134

Author(s):

Carolyn S Calfee ◽

Kevin L Delucchi ◽

Pratik Sinha ◽

Michael A Matthay ◽

Jonathan Hackett ◽

...

Keyword(s):

Respiratory Distress ◽

Distress Syndrome ◽

Controlled Trial ◽

Secondary Analysis ◽

Differential Response ◽

Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(19)30417-5 ◽

2020 ◽

Vol 8 (3) ◽

pp. 267-276 ◽

Cited By ~ 175

Author(s):

Jesús Villar ◽

Carlos Ferrando ◽

Domingo Martínez ◽

Alfonso Ambrós ◽

Tomás Muñoz ◽

...

Keyword(s):

Respiratory Distress ◽

Distress Syndrome ◽

Controlled Trial ◽

Dexamethasone Treatment ◽